Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $2.38 | Prev. Close $2.28 | Circuit Range N/A |
Day Range $2.38 - $2.73 | Year Range $0.97 - $17.09 | Volume 3,601 |
Average Traded $2.58 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
18-Mar-26 | $2.35 | $2.28 | +0.44% |
17-Mar-26 | $2.52 | $2.27 | -6.20% |
16-Mar-26 | $2.95 | $2.42 | -13.73% |
13-Mar-26 | $4.35 | $2.81 | -38.62% |
12-Mar-26 | $4.67 | $4.57 | -2.56% |
11-Mar-26 | $4.90 | $4.69 | -6.76% |
10-Mar-26 | $4.76 | $5.03 | +3.71% |